对瓣膜性心脏病患者的评估:一种综合方法

B. Carabello
{"title":"对瓣膜性心脏病患者的评估:一种综合方法","authors":"B. Carabello","doi":"10.5339/AHCSPS.2011.15","DOIUrl":null,"url":null,"abstract":"In managing the patient with valvular heart disease (VHD), three major issues must be addressed: (1) assessment of the severity of disease, (2) the effect the disease is having or is likely to have on the patient and his/her cardiovascular system, and (3) the timing and type of intervention to be used to correct the lesion. Existing guidelines are helpful in addressing these tenets in many cases, often using quantifiable parameters to aid the clinician in making key clinical decisions. Many times these guidelines allow the physician and patient to arrive easily at a management strategy. However, in other cases it may take every piece of available data to develop a management plan that is still only a best guess at the proper course to take. Overall, the indications for intervention in VHD are straightforward: valvotomy (in mitral stenosis), or valve repair or valve replacement is indicated when severe VHD causes symptoms or cardiac dysfunction. In some cases, low-risk intervention such as mitral valve repair may be undertaken in the absence of symptoms or dysfunction when it seems inevitable that deterioration will occur because of markedly severe disease. These assessments are rarely made using one test and usually require the integration of all the clinical acumen that can be summoned to address the issues above. The following will summarize the general approach to the assessment of VHD severity, impact, and timing of intervention, with attention paid to the specifics of each individual disease.","PeriodicalId":416388,"journal":{"name":"Global Cardiology Science and Practice","volume":"51 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2011-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Assessment of the patient with valvular heart disease: An integrative approach\",\"authors\":\"B. Carabello\",\"doi\":\"10.5339/AHCSPS.2011.15\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In managing the patient with valvular heart disease (VHD), three major issues must be addressed: (1) assessment of the severity of disease, (2) the effect the disease is having or is likely to have on the patient and his/her cardiovascular system, and (3) the timing and type of intervention to be used to correct the lesion. Existing guidelines are helpful in addressing these tenets in many cases, often using quantifiable parameters to aid the clinician in making key clinical decisions. Many times these guidelines allow the physician and patient to arrive easily at a management strategy. However, in other cases it may take every piece of available data to develop a management plan that is still only a best guess at the proper course to take. Overall, the indications for intervention in VHD are straightforward: valvotomy (in mitral stenosis), or valve repair or valve replacement is indicated when severe VHD causes symptoms or cardiac dysfunction. In some cases, low-risk intervention such as mitral valve repair may be undertaken in the absence of symptoms or dysfunction when it seems inevitable that deterioration will occur because of markedly severe disease. These assessments are rarely made using one test and usually require the integration of all the clinical acumen that can be summoned to address the issues above. The following will summarize the general approach to the assessment of VHD severity, impact, and timing of intervention, with attention paid to the specifics of each individual disease.\",\"PeriodicalId\":416388,\"journal\":{\"name\":\"Global Cardiology Science and Practice\",\"volume\":\"51 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global Cardiology Science and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5339/AHCSPS.2011.15\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Cardiology Science and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5339/AHCSPS.2011.15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

摘要

在管理瓣膜性心脏病(VHD)患者时,必须解决三个主要问题:(1)疾病严重程度的评估;(2)疾病对患者及其心血管系统的影响或可能产生的影响;(3)用于纠正病变的干预时机和类型。在许多情况下,现有的指南有助于解决这些原则,通常使用可量化的参数来帮助临床医生做出关键的临床决策。很多时候,这些指导方针使医生和病人很容易达成一个管理策略。然而,在其他情况下,可能需要所有可用的数据来制定管理计划,而这仍然只是对适当路线的最佳猜测。总的来说,VHD干预的适应症很简单:当严重的VHD引起症状或心功能障碍时,应行瓣膜切开术(二尖瓣狭窄)或瓣膜修复或瓣膜置换术。在某些情况下,在没有症状或功能障碍的情况下,当明显严重的疾病似乎不可避免地会发生恶化时,可以采取低风险的干预措施,如二尖瓣修复。这些评估很少使用一种测试进行,通常需要整合所有可以召集的临床敏锐性来解决上述问题。以下将总结评估VHD严重程度、影响和干预时机的一般方法,并注意每种疾病的具体情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Assessment of the patient with valvular heart disease: An integrative approach
In managing the patient with valvular heart disease (VHD), three major issues must be addressed: (1) assessment of the severity of disease, (2) the effect the disease is having or is likely to have on the patient and his/her cardiovascular system, and (3) the timing and type of intervention to be used to correct the lesion. Existing guidelines are helpful in addressing these tenets in many cases, often using quantifiable parameters to aid the clinician in making key clinical decisions. Many times these guidelines allow the physician and patient to arrive easily at a management strategy. However, in other cases it may take every piece of available data to develop a management plan that is still only a best guess at the proper course to take. Overall, the indications for intervention in VHD are straightforward: valvotomy (in mitral stenosis), or valve repair or valve replacement is indicated when severe VHD causes symptoms or cardiac dysfunction. In some cases, low-risk intervention such as mitral valve repair may be undertaken in the absence of symptoms or dysfunction when it seems inevitable that deterioration will occur because of markedly severe disease. These assessments are rarely made using one test and usually require the integration of all the clinical acumen that can be summoned to address the issues above. The following will summarize the general approach to the assessment of VHD severity, impact, and timing of intervention, with attention paid to the specifics of each individual disease.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信